Efficacy and safety of dose-dense neoadjuvant chemotherapy with nab-paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer

CONCLUSIONS: Neoadjuvant dose-dense biweekly nanoparticle albumin-bound paclitaxel followed by dose-dense epirubicin and cyclophosphamide was effective, especially in patients with triple-negative disease, and feasible with pegfilgrastim support.PMID:37609671 | DOI:10.1093/jjco/hyad112

Source: Clinical Breast Cancer - August 23, 2023 Category: Cancer & Oncology Authors: Akiko Matsumoto Hiromitsu Jinno Saki Naruse Yuka Isono Yuka Maeda Ayana Sato Miki Yamada Tatsuhiko Ikeda Yuko Sasajima Source Type: research